Chronic peripheral administration of the angiotensin II AT1 receptor antagonist Candesartan blocks brain AT1 receptors

Brain Research

Volumn 871, Issue 1, 2000, Pages 29-38

  Nishimura, Yasuaki ^a,b   Ito, Takeshi ^a,b   Hoe, Kwang Lae ^a,c   Saavedra, Juan M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b GIFU UNIVERSITY   (Japan)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Angiotensin II; Angiotensin II receptor subtypes; Autoradiography; In situ hybridization; Receptor antagonists; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; CANDESARTAN; LOSARTAN; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BLOOD PRESSURE; BRAIN REGION; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALS; ANTIHYPERTENSIVE AGENTS; AUTORADIOGRAPHY; BENZIMIDAZOLES; BLOOD PRESSURE; BRAIN; GENE EXPRESSION REGULATION; INFUSIONS, PARENTERAL; KIDNEY GLOMERULUS; MALE; ORGAN SPECIFICITY; RATS; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RNA, MESSENGER; TETRAZOLES; TRANSCRIPTION, GENETIC; ZONA GLOMERULOSA;

EID: 0034648049     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02377-5     Document Type: Article

References (34)

1. J.D. Bui, B. Kimura, M.I. Phillips, Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood brain barrier, Eur. J. Pharmacol. 219 (1992) 147-151.
2. E. Castrén, J.M. Saavedra, Repeated stress increases the density of angiotensin II binding sites in rat paraventricular nucleus and subfornical organ, Endocrinology 122 (1988) 370-372.
3. J. Culman, C. von Heyer, B. Piepenburg, W. Rascher, T. Unger, Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats, Eur. J. Pharmacol. 367 (1999) 255-265.
4. 125I]CGP 42112A, Neuroreport 4 (1993) 103-105.
5. 125I]CGP 42112, Brain Res. 677 (1995) 29-38.
6. Y. Inada, T. Wada, M. Ojima, T. Sanada, Y. Shibouta, R. Kanagawa, Y. Ishimura, Y. Fujisawa, K. Nishikawa, Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats, Clin. Exp. Hypertens. 19 (1997) 1079-1099.
7. T. Inagami, D.-F. Guo, Y. Kitami, Molecular biology of angiotensin II receptors: an overview, J. Hypertens. 12 (1994) 583-594.
8. 2 angiotensin II receptor subtype gene expression in rat brain, Neuroreport 6 (1995) 2549-2552.
9. 1B angiotensin II receptor messenger RNA in forebrain of two-week-old rats, Am. J. Physiol. 271 (1996) E104-E112.
10. A. Kamitani, K. Higahsimori, K. Kohara, J. Higaki, H. Mikami, T. Ogihara, The effects of central administration of angiotensin II type-1 receptor antagonist, CV-11974, in nephrectomized spontaneously hypertensive rats, Clin. Exp. Pharmacol. Physiol. 21 (1994) 271-276.
11. Z. Li, J.S. Bains, A.V. Ferguson, Functional evidence that the angiotensin antagonist losartan crosses the blood-brain barrier in the rat, Brain Res. Bull. 30 (1992) 33-39.
12. 1 receptors in the nucleus of the solitary tract to attenuate the baroreceptor reflex, Am. J. Physiol. 275 (1998) R1611-1619.
13. 1 receptor blocker: pharmacology, antihypertensive efficacy, renal function, and renoprotection, J. Am. Soc. Nephrol. 10 (1999) S248-S254.
14. T.J. Murphy, R.W. Alexander, K.K. Griendling, M.S. Runge, K.E. Bernstein, Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor, Nature (London) 351 (1991) 233-236.
15. 125I] brain paste standards for use in quantitative receptor autoradiography, J. Neurosci. Methods 30 (1989) 247-253.
16. 1 receptor expression, Basic Res. Cardiol. 93 (Suppl. 2) (1998) 63-68.
17. R.D. O'Shea, A.L. Gundlach, Quantitative analysis of in situ hybridization histochemistry, in: W. Wisden, B.J. Morris (Eds.), In Situ Hybridization Protocols For the Brain, Academic Press, New York, 1994, pp. 57-78.
18. I.H. Page, in: Hypertension Mechanisms, Grune and Stratton, New York, 1987, p. 1102pp.
19. G. Paxinos, C. Watson, in: The Rat Brain in Stereotaxic Coordinates, Academic Press, Orlando, FL, 1986, p. 249pp.
20. C. Polidori, R. Ciccocioppo, R. Nisato, C. Cazaubon, M. Massi, Evaluation of the ability of irbesartan to cross the blood-brain barrier following acute intragastric treatment, Eur. J. Pharm. 352 (1998) 15-21.
21. 1 receptor antagonists to cross the blood-brain barrier in rats, Eur. J. Pharmacol. 307 (1996) 259-267.
22. N.E. Rowland, A. Morien, M.J. Fregly, Losartan inhibition of angiotensin-related drinking and Fos immunoreactivity in hypertensive and hypotensive contexts, Brain Res. 742 (1996) 253-259.
23. J.M. Saavedra, Brain and pituitary Angiotensin, Endocr. Rev. 13 (1992) 329-380.
24. J.M. Saavedra, Emerging features of brain angiotensin receptors, Reg. Pept. 85 (1999) 31-45.
25. P.S. Sever, Key features of candesartan cilexetil and a comparison with other angiotensin II receptor antagonists, J. Hum. Hypertens. 13 (Suppl. 1) (1999) S3-S10.
26. K. Shigematsu, J.M. Saavedra, L.M. Plunkett, M. Kurihara, F.M.A. Correa, Angiotensin II binding site in the anteroventral-third ventricle (AV3V) area and related structures of the rat brain, Neurosci. Lett. 67 (1986) 37-41.
27. K. Song, H. Kanehara, S. Takai, N. Shiota, T. Wada, Y. Inada, M. Miyazaki, Inhibition of the angiotensin II type 1 receptor by TCV-116: quantitation by in vitro autoradiography, Jpn. J. Pharmacol. 79 (1999) 131-139.
28. K. Song, J. Zhuo, F.A.O. Mendelsohn, Access of peripherally administered DuP 753 to rat brain angiotensin II receptors, Br. J. Pharmacol. 104 (1992) 771-772.
29. J.P. Tang, A. Rakhit, F.L. Douglas, S. Melethil, Effect of chronic hypertension on the blood-brain barrier permeability of libenzapril, Pharm. Res. 9 (1992) 236-243.
30. P.B. Timmermans, Pharmacological properties of angiotensin II receptor antagonists, Can. J. Cardiol. 15 (Suppl. 7) (1999) 26F-28F.
31. P.B.M.W.M. Timmermans, T. Inagami, J.M. Saavedra, R. Ardaillou, C.R. Rosenfeld, F.A.O. Mendelsohn, Angiotensin receptor subtypes and their pharmacology, in: A.C. Cuello, B. Collier (Eds.), Pharmacological Sciences: Perspectives For Research and Therapy in the Late 1990s, Birkhäuser, Basel, Switzerland, 1995, pp. 37-58.
32. 2) in rat brain, Am. J. Physiol. 261 (1991) R209-R216.
33. P.C. Wong, W.A. Price, A.T. Chiu, J.V. Duncia, D.J. Carini, R.R. Wexler, A.L. Johnson, P.M.W.M. Timmermans, Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent, J. Pharmacol. Exp. Ther. 252 (1990) 719-725.
34. 1 angiotensin II receptors in rat brain, kidney and adrenal glands demonstrated by in vitro autoradiography, Clin. Exp. Pharmacol. Physiol. 21 (1994) 557-567.